THE USE OF ASSOCIATION DATA TO IDENTIFY FAMILY MEMBERS AT HIGH-RISK FOR MARKER-LINKED DISEASES

被引：0
|
作者：
CONTE, WJ
ROTTER, JI
机构：
[1] UNIV CALIF LOS ANGELES, LOS ANGELES CTY HARBOR MED CTR,SCH MED,DEPT MED, DIV MED GENET, TORRANCE, CA 90509 USA
[2] UNIV CALIF LOS ANGELES, LOS ANGELES CTY HARBOR MED CTR,SCH MED, DEPT PEDIAT,DIV MED GENET, TORRANCE, CA 90509 USA
来源：
AMERICAN JOURNAL OF HUMAN GENETICS | 1984年 / 36卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：152 / 166
页数：15
相关论文
共 50 条
  • [21] COMMUNITY PHARMACY DATA-BASES TO IDENTIFY PATIENTS AT HIGH-RISK FOR HYPERCHOLESTEROLEMIA
    GARDNER, SF
    SKELTON, DR
    ROLLINS, SD
    HASTINGS, JK
    PHARMACOTHERAPY, 1995, 15 (03): : 292 - 296
  • [22] REDUCING FALLS THROUGH THE USE OF COLORED PLACARDS TO IDENTIFY HIGH-RISK PATIENTS
    Edmondson, Tabitha
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [23] Proposing the use of hyponatremia as a marker to help identify high risk individuals for lung cancer
    Kasi, Pashtoon Murtaza
    MEDICAL HYPOTHESES, 2012, 79 (03) : 327 - 328
  • [24] Assessment of Early Evidence of Multiple Sclerosis in a Prospective Study of Asymptomatic High-Risk Family Members
    Xia, Zongqi
    Steele, Sonya U.
    Bakshi, Anshika
    Clarkson, Sarah R.
    White, Charles C.
    Schindler, Matthew K.
    Nair, Govind
    Dewey, Blake E.
    Price, Lauren R.
    Ohayon, Joan
    Chibnik, Lori B.
    Cortese, Irene C. M.
    De Jager, Philip L.
    Reich, Daniel S.
    JAMA NEUROLOGY, 2017, 74 (03) : 291 - 298
  • [25] CARDIOPULMONARY-RESUSCITATION (CPR) TRAINING - CONSEQUENCES FOR FAMILY MEMBERS OF HIGH-RISK CARDIAC PATIENTS
    DRACUP, K
    GUZY, PM
    TAYLOR, SE
    BARRY, J
    ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (09) : 1757 - 1761
  • [26] Using Peer Mentors to Screen for CKD at Dialysis Units: Targeting High-Risk Family Members
    Swartz, June E.
    Perry, Erica
    Joy, Sally
    Swartz, Richard D.
    DIALYSIS & TRANSPLANTATION, 2011, 40 (06) : 246 - 251
  • [27] Use of family history to identify adults at increased risk for chronic diseases and mendelian disorders.
    Scheuner, MT
    Yoon, PW
    Khoury, MJ
    GENETICS IN MEDICINE, 2004, 6 (04) : 385 - 385
  • [28] The association of metformin use with keratinocyte carcinoma development in high-risk patients
    Misitzis, Angelica
    Stratigos, Alexander J.
    Beatson, Meghan
    Mastorakos, George
    Dellavalle, Robert P.
    Weinstock, Martin A.
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [29] USE OF HOST FACTORS TO IDENTIFY PEOPLE AT HIGH-RISK FOR CUTANEOUS MALIGNANT-MELANOMA
    MARRETT, LD
    KING, WD
    WALTER, SD
    FROM, L
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1992, 147 (04) : 445 - 452
  • [30] USE OF URINARY METABOLOMICS TO IDENTIFY HIGH-RISK CLEAR CELL RENAL CELL CARCINOMA
    Gupta, Mohit
    Patel, Hiten
    Semerjian, Alice
    Gorin, Michael
    Johnson, Michael
    Allaf, Mohamad
    Pierorazio, Phillip
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1198 - E1198
12345